TDC
59
10
CME
42
-4
DUK
64
2
NVDA
52
-3
FRT
36
-2
CHK
48
15
ITW
62
-2
TROW
34
-5
DHI
53
-3
CCL
68
-4
UAL
56
2
BF.B
43
-7
XRAY
31
-3
IFF
56
-3
SHW
71
-2
KEY
51
-3
FOXA
48
7
NTAP
60
2
SWKS
38
-2
AA
41
-4
TDC
59
10
CME
42
-4
DUK
64
2
NVDA
52
-3
FRT
36
-2
CHK
48
15
ITW
62
-2
TROW
34
-5
DHI
53
-3
CCL
68
-4
UAL
56
2
BF.B
43
-7
XRAY
31
-3
IFF
56
-3
SHW
71
-2
KEY
51
-3
FOXA
48
7
NTAP
60
2
SWKS
38
-2
AA
41
-4
Financhill
Back

SoftBank Group Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
28

SFTBF
SoftBank Group

Last Price:
58.65
Seasonality Move:
1.92%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
28
SoftBank Group (SFTBF) is a Sell

Is SoftBank Group a Buy, Sell or Hold?

  • The current SoftBank Group [SFTBF] share price is $58.65. The Score for SFTBF is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • SFTBF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SFTBF Stock Price Chart

What is SoftBank Group's stock price today?

  • The SoftBank Group share price today is $58.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SFTBF is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

SFTBF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.46 Buy
Relative Strength Index (14 RSI): 53.59 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.35 - 59.31) Buy
Bollinger Bands (100): (52.33 - 65.17) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

SFTBF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.96 Sell
20-day SMA: 56.63 Buy
50-day SMA: 58.39 Buy
200-day SMA: 54.6 Buy
8-day EMA: 58.22 Buy
20-day EMA: 57.3 Buy
50-day EMA: 57.84 Buy
200-day EMA: 55 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

SoftBank Group Earnings Growth & SFTBF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

SoftBank Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):